N-(p-amylcinnamoyl) Anthranilic Acid 250mg | ≥99%
CSNpharm
N-(p-amylcinnamoyl) Anthranilic Acid is a PLA2 inhibitor and TRP channel modulator.
More Information Supplier Page
N-(p-amylcinnamoyl) Anthranilic Acid is a PLA2 inhibitor and TRP channel modulator.
More Information Supplier Page
N-(p-amylcinnamoyl) Anthranilic Acid is a PLA2 inhibitor and TRP channel modulator.
More Information Supplier Page
ZK824859 is a new structural class uPA inhibitor with potential effect on treating multiple sclerosis.
More Information Supplier Page
ZK824859 is a new structural class uPA inhibitor with potential effect on treating multiple sclerosis.
More Information Supplier Page
FMOC-L-THR is a GlcNAc modified threonine and it is involved in the regulation of multiple signaling pathways in cells.
More Information Supplier Page
FMOC-L-THR is a GlcNAc modified threonine and it is involved in the regulation of multiple signaling pathways in cells.
More Information Supplier Page
FMOC-L-THR is a GlcNAc modified threonine and it is involved in the regulation of multiple signaling pathways in cells.
More Information Supplier Page
Rumodolinl, a analog of prostacyclin, is an agonist of IP receptor that used clinically to treat pulmonary arterial hypertension. It is a vasodilator with antithrombotic and anti-inflammatory properties.
More Information Supplier Page
Rumodolinl, a analog of prostacyclin, is an agonist of IP receptor that used clinically to treat pulmonary arterial hypertension. It is a vasodilator with antithrombotic and anti-inflammatory properties.
More Information Supplier Page
Rumodolinl, a analog of prostacyclin, is an agonist of IP receptor that used clinically to treat pulmonary arterial hypertension. It is a vasodilator with antithrombotic and anti-inflammatory properties.
More Information Supplier Page